Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays
- PMID: 31451572
- PMCID: PMC6711926
- DOI: 10.1128/JCM.00779-19
Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays
Keywords: BD MAX MDR TB; INH resistance.
Comment in
-
Reply to Murray et al., "Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays".J Clin Microbiol. 2019 Aug 26;57(9):e00984-19. doi: 10.1128/JCM.00984-19. Print 2019 Sep. J Clin Microbiol. 2019. PMID: 31451575 Free PMC article. No abstract available.
Comment on
-
GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB).J Clin Microbiol. 2019 May 24;57(6):e00537-19. doi: 10.1128/JCM.00537-19. Print 2019 Jun. J Clin Microbiol. 2019. PMID: 30971464 Free PMC article. No abstract available.
References
-
- Mokaddas E, Ahmad S, Samir I. 2008. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996–2005. Int J Tuberc Lung Dis 12:319–325. - PubMed
-
- Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S. 2019. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. BMC Infect Dis 19:3. doi:10.1186/s12879-018-3638-z. - DOI - PMC - PubMed
-
- Romanowski K, Campbell JR, Oxlade O, Fregonese F, Menzies D, Johnston JC. 2019. The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: a modelling study. PLoS One 14:e0211355. doi:10.1371/journal.pone.0211355. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical